法国马赛消防站COVID-19暴发调查
暴发罹患率为27%,识别出两次病毒引入,无症状病例未引发第三代病例,基于早期症状筛查与自我隔离的管理策略有效。
要点
- 无症状病例未成为第三代病例传染源,尽管未戴口罩工作。
- 基于早期症状研究与自我隔离的管理策略有效。
核心结论
- 该消防站COVID-19暴发罹患率为27%,无症状病例在本次暴发中未发挥显著传播作用,基于早期症状筛查联合自我隔离的管理策略有效。
研究设计与样本
- 对马赛一消防站在暴发期间工作的全部85名消防员进行问卷调查并采样,开展SARS-CoV-2 RT-PCR和病毒中和试验。
主要发现
- 22名消防员具有特异性中和抗体,4例无症状和18例有症状者检出中和抗体。
- 中和抗体最早在症状出现后7天检出,80%在症状出现后15天具有中和抗体。
- 症状出现后13天有1份病毒培养阳性。
关键数值与推荐
- 确诊病例定义为SARS-CoV-2逆转录(RT)-PCR阳性和/或中和抗体阳性者。
- 暴发罹患率为27%。
- 识别出两次病毒引入,分别通过1例症状前病例和1例轻症状病例。
临床怎么用
- 在集体工作场所暴发中,应早期筛查临床症状并结合自我隔离进行管理。
- 无症状感染者虽未戴口罩工作,但未引发第三代病例,提示其传播作用有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We investigated a COVID-19 outbreak at a fire station in Marseille, France. Confirmed cases were defined as individuals with positive SARS-CoV-2 reverse transcription (RT)-PCR and/or neutralising antibodies. All 85 firefighters at work during the outbreak period were included after questioning and sampled for RT-PCR and viral neutralisation assay. Twenty-three firefighters were confirmed positive, 19 of them were symptomatic, and four asymptomatic cases were confirmed by virus neutralisation. A total of 22 firefighters had specific neutralising antibodies against SARS-CoV-2. Neutralising antibodies were found in four asymptomatic and 18 symptomatic cases. Eleven symptomatic cases had high titres (≥ 1:80). The earliest detection of neutralising antibodies was 7 days after symptom onset, and 80% had neutralising antibodies 15 days after onset. One viral culture was positive 13 days after onset. The attack rate was 27%. We identified two introductions of the virus in this outbreak, through a presymptomatic and a paucisymptomatic case. Asymptomatic cases were not the source of a third generation of cases, although they worked without wearing a mask, indicating that asymptomatic cases did not play a significant role in this outbreak. Management and strategy based on early research of clinical signs associated with self-quarantine was effective.
引用
- Durand GA, de Laval F, de Bonet d'Oléon A, et al. COVID-19 outbreak among French firefighters, Marseille, France, 2020. Euro Surveill. 2021. PMID: 34651571. doi:10.2807/1560-7917.ES.2021.26.41.2001676
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。